⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACAD News
Acadia Pharmaceuticals Inc.
Form 8-K
sec.gov
ACAD
Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career
businesswire.com
ACAD
STOKE Shoes Named Official Footwear Partner of Star Speedway
prnewswire.com
ACAD
Black Book Releases 2026 State of Digital Healthcare Technology in Accountable Care Organizations eBook
accessnewswire.com
ACAD
COHR
Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026
businesswire.com
ACAD
STOKE Shoes Drops SS26 Summer Lineup Built for Heat, Hustle, and Wide Feet
prnewswire.com
ACAD
SSNC
Acadia Pharmaceuticals Announces DAYBUE ® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome
businesswire.com
ACAD
CORRECTION FROM SOURCE: CIO 100 Awards & Conference Announces 2026 CIO 100 Honorees, Recognizing Enterprise-Scale Technology Leadership
accessnewswire.com
HPE
IBM
AVNT
BAC
BSM
CTSH
DELL
DOX
DG
DD
ECL
FDX
FICO
INTC
JNJ
MA
OII
PEP
QCOM
RS
S
TMO
TRV
UNM
UPS
VZ
WCC
ABBV
ACAD
AES
ALB
ALLY
AMAT
AZN
T
AVPT
CBRE
CI
COST
DE
EL
GE
GILD
JLL
JPM
KHC
LMT
MS
NWSA
PENN
PFE
REGN
ROK
SAN
SM
SIRI
TMUS
TRIP
WEN
CVS
AMZN
GOOGL
MSFT
ORCL
CRM
ADBE
NFLX
NVDA
AMD
CSCO
HPQ
ACN
ADP
AMGN
BA
CAT
CMCSA
COP
DIS
DOW
EOG
HON
KO
LIN
LRCX
MDT
META
MRK
MU
NEE
RTX
SBUX
SMCI
SNPS
SO
SPG
TCOM
TGT
TXN
UNH
VRTX
WFC
XOM
ZTS
Nuevo informe: la enfermedad de Parkinson costó a EE.UU. $82,200 millones en 2024, superando proyecciones anteriores
prnewswire.com
ABBV
ACAD
New Report: In 2024, Parkinson's Disease Cost the U.S. $82.2 Billion, Surpassing Previous Projections
prnewswire.com
ABBV
ACAD